Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 7946 Ivanhoe Ave, Suite 201, La Jolla,california 92037,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.ensysce.com
- Keywords
- Drug Delivery, Pain, Oncology, Single-Walled Carbon Nanotubes, Opioids, Abuse Deterrent Technology, Overdose Protection, prodrug.
- HQ
- La Jolla, California
Ensysce Biosciences Questions
Ensysce Biosciences's website is https://www.ensysce.com
Ensysce Biosciences's LinkedIn profile is https://www.linkedin.com/company/ensyscebio
Ensysce Biosciences has
13 employees.
View email and phone details for 13
employees at Ensysce Biosciences.
Ensysce Biosciences's industry is
Biotechnology Research
Ensysce Biosciences's top competitors are
Elevation Oncology,
Quotient Sciences,
Reviva Pharmaceuticals,
Structure Therapeutics,
Edesa Biotech, Inc.,
Biomerica, Inc.,
89bio,
Engrail Therapeutics,
Cyclacel Pharmaceuticals, Inc.,
Dermata Therapeutics, Inc..
Ensysce Biosciences's categories are Biotechnology Research
Ensysce Biosciences's founding year is 2008
